| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.CCR.2009.08.013 |
| P698 | PubMed publication ID | 19732718 |
| P50 | author | William G. Kaelin | Q1603351 |
| P2860 | cites work | Understanding the Warburg effect: the metabolic requirements of cell proliferation | Q24604760 |
| A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas | Q24811594 | ||
| Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer | Q28267037 | ||
| Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia | Q28586744 | ||
| HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability | Q29615945 | ||
| Tumor cell metabolism: cancer's Achilles' heel | Q29619809 | ||
| The yeast metabolic cycle: insights into the life of a eukaryotic cell | Q37141044 | ||
| Fumarate hydratase deficiency in renal cancer induces glycolytic addiction and hypoxia-inducible transcription factor 1alpha stabilization by glucose-dependent generation of reactive oxygen species. | Q37275151 | ||
| Cells silenced for SDHB expression display characteristic features of the tumor phenotype | Q39976312 | ||
| Loss of the SdhB, but Not the SdhA, subunit of complex II triggers reactive oxygen species-dependent hypoxia-inducible factor activation and tumorigenesis. | Q40060668 | ||
| Redox stress is not essential for the pseudo-hypoxic phenotype of succinate dehydrogenase deficient cells. | Q40263177 | ||
| P433 | issue | 3 | |
| P921 | main subject | paraganglioma | Q581592 |
| P304 | page(s) | 180-182 | |
| P577 | publication date | 2009-09-01 | |
| P1433 | published in | Cancer Cell | Q280018 |
| P1476 | title | SDH5 mutations and familial paraganglioma: somewhere Warburg is smiling | |
| P478 | volume | 16 |
| Q36518279 | Acetoacetate Accelerates Muscle Regeneration and Ameliorates Muscular Dystrophy in Mice |
| Q33882790 | BRCA1 induces major energetic metabolism reprogramming in breast cancer cells. |
| Q37957006 | Cancer and altered metabolism: potential importance of hypoxia-inducible factor and 2-oxoglutarate-dependent dioxygenases |
| Q37802750 | Cancer-associated IDH mutations: biomarker and therapeutic opportunities |
| Q49787613 | Characterization and metabolic synthetic lethal testing in a new model of SDH-loss familial pheochromocytoma and paraganglioma. |
| Q38091325 | Current concepts in organic acidurias: understanding intra- and extracerebral disease manifestation |
| Q36385589 | Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion. |
| Q36377723 | Genetic insights into OXPHOS defect and its role in cancer |
| Q30457876 | High-throughput screening for growth inhibitors using a yeast model of familial paraganglioma |
| Q27692015 | IDH mutations in tumorigenesis and their potential role as novel therapeutic targets |
| Q37837594 | Inborn and acquired metabolic defects in cancer |
| Q58801103 | Inborn-like errors of metabolism are determinants of breast cancer risk, clinical response and survival: a study of human biochemical individuality |
| Q37177814 | Influence of metabolism on epigenetics and disease |
| Q28306956 | Inhibition of 2-oxoglutarate dependent oxygenases |
| Q34279708 | Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors |
| Q34768395 | Insights into the pathogenesis and treatment of cancer from inborn errors of metabolism |
| Q36969070 | Interplay between Metabolism and Epigenetics: A Nuclear Adaptation to Environmental Changes |
| Q47594814 | Investigations on the role of a solvent tunnel in the α-ketoglutarate dependent oxygenase factor inhibiting HIF (FIH). |
| Q24617423 | Lithocholic bile acid selectively kills neuroblastoma cells, while sparing normal neuronal cells |
| Q46631747 | Loss of SDHB Elevates Catecholamine Synthesis and Secretion Depending on ROS Production and HIF Stabilization |
| Q33557931 | Low aerobic mitochondrial energy metabolism in poorly- or undifferentiated neuroblastoma |
| Q38662384 | Metabolic changes associated with tumor metastasis, part 2: Mitochondria, lipid and amino acid metabolism |
| Q38530400 | Metabolic dysregulation in monogenic disorders and cancer - finding method in madness |
| Q36668449 | New cancer targets emerging from studies of the Von Hippel‐Lindau tumor suppressor protein |
| Q90860049 | Oncometabolites in renal cancer |
| Q36467162 | Pheochromocytoma and paraganglioma |
| Q43045797 | Q&A: Cancer: clues from cell metabolism |
| Q38118122 | Rare insights into cancer biology |
| Q33637176 | Research resource: Transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas |
| Q90533150 | SDH5 Depletion Enhances Radiosensitivity by Regulating p53: A New Method for Noninvasive Prediction of Radiotherapy Response |
| Q35869638 | Succinate dehydrogenase (SDH) D subunit (SDHD) inactivation in a growth-hormone-producing pituitary tumor: a new association for SDH? |
| Q24320050 | Succinate dehydrogenase 5 (SDH5) regulates glycogen synthase kinase 3β-β-catenin-mediated lung cancer metastasis |
| Q35067274 | Succinate dehydrogenase inhibition leads to epithelial-mesenchymal transition and reprogrammed carbon metabolism |
| Q39205930 | Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors |
| Q99248486 | The evolving metabolic landscape of chromatin biology and epigenetics |
| Q27667409 | The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases |
| Q28598099 | The role of PHD2 mutations in the pathogenesis of erythrocytosis |
Search more.